Medico Remedies Limited (NSE:MEDICO)

Medico Remedies Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	131.15	100.93	82.91	72.42	48.12
Depreciation & Amortization	30.95	29.76	28.6	27.21	22.18
Other Amortization	-	0.54	0.2	-	-
Loss (Gain) From Sale of Assets	-0.08	0	-0.03	0.01	0.39
Provision & Write-off of Bad Debts	3.29	-5.82	6.26	-1.39	0.62
Other Operating Activities	-3.41	-4.02	-0.96	4.91	0.74
Change in Accounts Receivable	-251.41	-69.66	-136.13	-55.62	-38.81
Change in Inventory	-32.89	-103.89	33.62	-15.91	-35.57
Change in Accounts Payable	146.15	32.01	5.26	38.89	17.49
Change in Other Net Operating Assets	35	69.06	4.66	11.16	43.46
Operating Cash Flow	58.74	48.92	24.38	81.67	58.62
Operating Cash Flow Growth	20.08%	100.67%	-70.15%	39.32%	-
Capital Expenditures	-44.9	-31.87	-24.78	-65.92	-59.13
Sale of Property, Plant & Equipment	0.65	0.04	0.08	0.05	30.1
Investment in Securities	-3.94	-0.85	-3	-0.87	-0.14
Other Investing Activities	2.92	1.05	0.94	0.71	0.6
Investing Cash Flow	-45.12	-34.6	-26.77	-66.04	-17.56
Long-Term Debt Repaid	-5.5	-5.2	-4.9	-4.6	-1.5
Net Debt Issued (Repaid)	-5.5	-5.2	-4.9	-4.6	-1.5
Other Financing Activities	-	-	-	-13.57	-56.21
Financing Cash Flow	-5.5	-5.2	-4.9	-18.17	-57.71
Miscellaneous Cash Flow Adjustments	0	-	-	-	-
Net Cash Flow	8.12	9.12	-7.29	-2.54	-16.65
Free Cash Flow	13.85	17.05	-0.4	15.75	-0.51
Free Cash Flow Growth	-18.79%	-	-	-	-
Free Cash Flow Margin	0.65%	1.13%	-0.03%	1.12%	-0.04%
Free Cash Flow Per Share	0.17	0.20	-0.01	0.19	-0.01
Cash Interest Paid	-	-	-	0.53	2.33
Cash Income Tax Paid	-	38.02	31.66	24.95	17.95
Levered Free Cash Flow	-50.51	-81.71	-12.13	-18.61	-11.65
Unlevered Free Cash Flow	-39.22	-76.37	-8.11	-14.99	-8.48
Change in Working Capital	-103.16	-72.48	-92.6	-21.48	-13.43

Source: S&P Global Market Intelligence. Standard template. Financial Sources.